Form EFFECT Aptose Biosciences Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 21, 2024 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Castill Health Announces Plans for Philippines Digital Healthcare Launch, Supported by Craig Astill and Caason Group
- New Cryptocurrency to Watch: Remittix Nears $33 Million as AVAX Trades Near $10 and Utility Takes Centre Stage
- Pepe Coin Price Prediction: PEPE Trades Near $0.0000040 as Remittix’s PayFi Tests Put Utility Back in Focus
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share